Interpublic Group to Present at the 2025 Morgan Stanley Technology, Media & Telecom Conference

New York, NY, Feb. 26, 2025 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) senior management will present at the 2025 Morgan Stanley Technology, Media & Telecom Conference on Tuesday, March 4th, 2025, at 2:30 pm Eastern Time/11:30 am Pacific Time, as scheduled.

A link to the live webcast will be posted on the day of the conference on the Investor Relations section of Interpublic’s website (http://investors.interpublic.com) where it will remain available for replay for 30 days.

# # #

About Interpublic
Interpublic (NYSE: IPG) (www.interpublic.com) is a values-based, data-fueled, and creatively-driven provider of marketing solutions. Home to some of the world’s best-known and most innovative communications specialists, IPG global brands include Acxiom, Craft, FCB, FutureBrand, Golin, Initiative, IPG Health, IPG Mediabrands, Jack Morton, KINESSO, MAGNA, McCann, Mediahub, Momentum, MRM, MullenLowe Global, Octagon, UM, Weber Shandwick and more. IPG is an S&P 500 company with total revenue of $10.7 billion in 2024.

# # #

Contact Information
Tom Cunningham
(Press)
(212) 704-1326

Jerry Leshne
(Analysts, Investors)
(212) 704-1439

Interpublic Group to Present at the 2025 Morgan Stanley Technology, Media & Telecom Conference

RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME

ROCKWOOL A/S – transactions in connection with share buy-back programme

Reporting on transactions in Danish Aerospace Company A/S’ shares by persons discharging managerial responsibilities and persons closely associated with them

Signify completes share repurchases to cover share-based remuneration and continues with the share repurchases for capital reduction

Ress Life Investments A/S publishes portfolio composition for Q1 2025

Topics

RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME

ROCKWOOL A/S – transactions in connection with share buy-back programme

Reporting on transactions in Danish Aerospace Company A/S’ shares by persons discharging managerial responsibilities and persons closely associated with them

Signify completes share repurchases to cover share-based remuneration and continues with the share repurchases for capital reduction

Ress Life Investments A/S publishes portfolio composition for Q1 2025

Believe’s majority shareholder, Upbeat BidCo, announces its intention to file a public buy-out offer, followed by a squeeze-out, on the shares it does not...

Higher cantonal composition authority approved the amendments to the terms of the 2025 convertible bond

Technip Energies awarded a FEED contract for Jet Zero’s Sustainable Aviation Fuel project in Australia

Related Articles

First Farmers Financial Corp. Announces Common Stock Buyback Program

Results of the Stellantis 2025 Annual General Meeting

Toll Brothers Announces New Luxury Home Community Coming Soon to Reno, Nevada

ABO-Group Environment acquires Délo Boringen, a Belgian specialist in environmental research

Southern Michigan Bancorp, Inc. Announces Fourth Quarter and Full Year 2024 Earnings

Company

Headlines

RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME

ROCKWOOL A/S – transactions in connection with share buy-back programme

Reporting on transactions in Danish Aerospace Company A/S’ shares by persons discharging managerial responsibilities and persons closely associated with them

Signify completes share repurchases to cover share-based remuneration and continues with the share repurchases for capital reduction

Newsletter